A recent
report published by Infinium Global Research on sirolimus market provides
in-depth analysis of segments and sub-segments in the global as well as
regional sirolimus market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional sirolimus market
over the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of global sirolimus market. According to
the report, the global sirolimus market is projected to grow at a sluggish CAGR
over the forecast period of 2019-2025.
Sirolimus is
therapeutically used to coat coronary stents, to prevent organ transplant
rejection and to treat a rare lung disease lymphangioleiomyomatosis. It works
by weakening the body’s immune system and help our body to accept the new organ
transplanted in the body. Sirolimus is administered orally in the form of a
tablet or solution. Furthermore, sirolimus has antitumor, antifungal, and
anti-smooth muscle proliferative roles.
The increased
rate of kidney transplantation and the occurrence of lifestyle-related diseases
are major factors driving the growth of the sirolimus market. According to the
U.S. Government, 36,528 kidney transplants were executed worldwide in 2018.
Additionally, the growth of improvement in health care infrastructure and
worldwide is driving the sirolimus market. This is due to increasing demand, a
new target population, and larger emerging markets. However, adverse effects observed with
sirolimus and pending approvals from regulatory bodies are restraining the
growth of the sirolimus market. Further research is carried out with
advancements in technology and other therapeutic uses of sirolimus, which in
turn, providing an opportunity for the growth sirolimus market.
Amongst the
geographies, the global sirolimus market is segmented in regions like North
America, Europe, Asia Pacific, Middle East, and Africa. North America dominates
the sirolimus market during the forecast period due to the high prevalence of
the lifestyle-related disorder. Furthermore, Europe is expected to have the
second largest region for this market and it is estimated to show healthy
growth in the forecasting period. It is due to heavy spending on research and
development. Asia-Pacific region will grow with a lucrative rate in the
forecast period. As increasing expenditure on the healthcare sector in
countries like India and China is growing. The growth of pharmaceutical
industries and increasing disposable income is expected to aid the growth of
the market in the near future.
The report on
global sirolimus market covers segments such as application and distribution
channel. On the basis of application, the sub-markets include
lymphangioleiomyomatosis (LAM), organ transplant rejection, sirolimus coated
balloons, and catheter devices. On the basis of distribution channel, the sub-markets
include hospital pharmacies, retail pharmacies, and online pharmacies.
The report
provides profiles of the companies in the market such as Intas Pharmaceuticals
Ltd, Cadila Healthcare Ltd, Torrent Pharmaceuticals Ltd., Stentys, Concept
Medical, Inc., Biocon Limited, Pfizer Inc., and Other Companies.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of sirolimus market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.